Boards
Bundled experience and expertise strengthen our company’s development.
Dr. Jens Stegemann
Chair of the Board / CEO and Co-Founder Breath TherapeuticsLeadership and biotech startup expertise with proven track record in rare lung diseases and orphan drug development
Over 20 years management experience in the pharmaceutical and med-tech industry
Dieter Hierner
Deputy Chairman of the Board / Active business angel and CEO of a family office.Extensive banking background.
More than 40 years of experience in retail, commercial and wholesale banking with exposure to corporate finance and financial institutions.
Furthermore, experience in business development in various international countries.
For the past several years instrumental for the creation of a Tech and Start-up platform for a private global bank in Bavaria.
Dr. Dietrich Bruchmann
InvestorCEO of Nuvisan Holding
Excellent track record in progessiv growth strategies, exits and M&A consulting
Dr. Gerhard Scheuch
Seed Investor / Founding ShareholderPhysicist / Scientist: Expert in respiratory therapeutics and development of inhaled therapeutics
Advisor to the European Medicines Agency (EMA) and the leading pharmaceutical companies in this field
Serial entrepreneur: Founder of globally successful companies
Business Angel and shareholder of various life science and healthcare start-ups
Expert Advisory Board
From the very start we develop our products with the support of experts: patients and doctors.
Ulrike Nowak
Health ScientistMedical Assistant
Asthmatic patient
Dr. Peter Haidl
Internist pneumologySpecialty hospital Kloster Grafschaft GmbH
Academic Teaching Hospital of the Philipps University of Marburg
Dr. Klaus Klütsch
Internist pneumologyDMP training for asthma and COPD
Supervision of lung sports groups
Frank Hennemann
Patient relations managerPharmaceutical and health advisor
Patient with Alpha1-Antitrypsin Deficiency